Dr. David Capper is professor of Molecular Neuropathology at Europe’s largest Hospital, the Charité Berlin and research group leader at the German Cancer Consortium (DKTK), partner site Berlin. His research focuses on the pathology and genetics of tumors of the central nervous system with a special focus on the development of specific diagnostic markers ("mutation-specific antibodies") and classification of brain tumors by genome-wide DNA methylation profiling. In addition, he headed the central pathology for several national and international clinical trials and registries (currently ongoing LOGGIC registry). He is speaker of the German Cancer Consortium (DKTK) program “Molecular Diagnostics”, board member of the Neurooncology Working Group (NOA) of the German Cancer Society and member of cIMPACT (Consortium to Inform Molecular and Practical Approaches to CNS Tumor Taxonomy).